Login
iscover
Saab Australia has delivered 131 separate modules under JP 2060 Phase 3 to the Commonwealth and are now scheduled for testing by Defence.
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Officially achieving Contract Material Release 1, the 131 separate modules which range from deployable surgical modules to training equipment, will be tested by Defence on the road to initial operating capability scheduled for late 2023, the company confirmed.
The modules are being delivered under JP 2060 Phase 3, valued at $384 million.
Under the project, Saab Australia has been contracted to deliver over 550 NATO Role 1 to 3 categorised health modules to Defence.
These include surgery, medical imaging, trauma, and intensive care modules.
Saab Australia has confirmed that it will oversee and sustain the capabilities, as well as provide training, from their new Deployable Health Capability Support Centre in Ipswich, a company spokesperson confirmed.
“I’m pleased the project has reached this important milestone and Saab looks forward to continuing to work closely with the Commonwealth to deliver the full JP 2060-3 capability,” said Saab Australia managing director Andy Keough CSC.
“The advanced deployable health capability that Saab is delivering will enable the Australian Defence Force to rapidly deploy lifesaving medical equipment, facilities, and services to locations across Australia and the world.”
While delivering the capabilities to Defence, Saab Australia has committed to further develop health solutions for Defence.
The company recently established their Deployable Health Capability Centre of Excellence in Melbourne, where they are expected to collaborate with industry and academia to provide advanced health solutions and are exploring export opportunities.
